Artemis Medicare Services Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
183.35 -0.40 (-0.22%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
180.85
Today’s High
188
52 Week Low
117.25
52 Week High
199
183.34 -0.54 (-0.29%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
180.53
Today’s High
185
52 Week Low
118.25
52 Week High
199.9
Key Metrics
- Market Cap (In Cr) 2517.61
- Beta 1.64
- Div. Yield (%) 0.24
- P/B 5.57
- TTM P/E 47.07
- Peg Ratio 1.96
- Sector P/E 26.79
- D/E 0.71
- Open Price 188
- Prev Close 183.75
Artemis Medicare Services Analysis
Price Analysis
-
1 Week3.23%
-
3 Months-2.09%
-
6 Month1.03%
-
YTD2.07%
-
1 Year46.34%
Risk Meter
- 37% Low risk
- 37% Moderate risk
- 37% Balanced Risk
- 37% High risk
- 37% Extreme risk
Artemis Medicare Services News
Stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks today
2 min read . 10 May 2024Maruti Suzuki, TCS, Cipla, Shree Cements top gainers, losers today
2 min read . 26 Jun 2023Artemis Medicare Services Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 878.57
- Selling/ General/ Admin Expenses Total
- 138.95
- Depreciation/ Amortization
- 40.32
- Other Operating Expenses Total
- 606.93
- Total Operating Expense
- 786.19
- Operating Income
- 92.39
- Net Income Before Taxes
- 68.45
- Net Income
- 49.14
- Diluted Normalized EPS
- 3.53
- Period
- 2024
- Total Assets
- 971.51
- Total Liabilities
- 523.16
- Total Equity
- 448.35
- Tangible Book Valueper Share Common Eq
- 29.2
- Period
- 2024
- Cashfrom Operating Activities
- 108.85
- Cashfrom Investing Activities
- -86.99
- Cashfrom Financing Activities
- -30.12
- Net Changein Cash
- -8.26
- Period
- 2023
- Total Revenue
- 737.43
- Selling/ General/ Admin Expenses Total
- 129.91
- Depreciation/ Amortization
- 31
- Other Operating Expenses Total
- 494.76
- Total Operating Expense
- 674.26
- Operating Income
- 63.17
- Net Income Before Taxes
- 50.61
- Net Income
- 38.6
- Diluted Normalized EPS
- 2.72
- Period
- 2023
- Total Assets
- 904.95
- Total Liabilities
- 501.8
- Total Equity
- 403.15
- Tangible Book Valueper Share Common Eq
- 26.4
- Period
- 2023
- Cashfrom Operating Activities
- 127.16
- Cashfrom Investing Activities
- -158.21
- Cashfrom Financing Activities
- 38.22
- Net Changein Cash
- 7.17
- Period
- 2022
- Total Revenue
- 554.8
- Selling/ General/ Admin Expenses Total
- 108.63
- Depreciation/ Amortization
- 22.19
- Other Operating Expenses Total
- 361.1
- Total Operating Expense
- 509.02
- Operating Income
- 45.78
- Net Income Before Taxes
- 37.18
- Net Income
- 31.81
- Diluted Normalized EPS
- 2.32
- Period
- 2022
- Total Assets
- 709.66
- Total Liabilities
- 350.24
- Total Equity
- 359.42
- Tangible Book Valueper Share Common Eq
- 23.69
- Period
- 2022
- Cashfrom Operating Activities
- 59.58
- Cashfrom Investing Activities
- -107.22
- Cashfrom Financing Activities
- 44.18
- Net Changein Cash
- -3.46
- Period
- 2021
- Total Revenue
- 408.4
- Selling/ General/ Admin Expenses Total
- 85.82
- Depreciation/ Amortization
- 21.51
- Other Operating Expenses Total
- 170.69
- Total Operating Expense
- 391.25
- Operating Income
- 17.16
- Net Income Before Taxes
- 7.53
- Net Income
- 6.49
- Diluted Normalized EPS
- 0.3
- Period
- 2021
- Total Assets
- 600.09
- Total Liabilities
- 279.9
- Total Equity
- 320.19
- Tangible Book Valueper Share Common Eq
- 20.84
- Period
- 2021
- Cashfrom Operating Activities
- 27.26
- Cashfrom Investing Activities
- -37.42
- Cashfrom Financing Activities
- 17.72
- Net Changein Cash
- 7.55
- Period
- 2020
- Total Revenue
- 565.02
- Selling/ General/ Admin Expenses Total
- 107.69
- Depreciation/ Amortization
- 22.63
- Other Operating Expenses Total
- 256.68
- Total Operating Expense
- 526.05
- Operating Income
- 38.97
- Net Income Before Taxes
- 30.63
- Net Income
- 19.79
- Diluted Normalized EPS
- 1.51
- Period
- 2020
- Total Assets
- 586.44
- Total Liabilities
- 273.2
- Total Equity
- 313.24
- Tangible Book Valueper Share Common Eq
- 20.26
- Period
- 2020
- Cashfrom Operating Activities
- 56.08
- Cashfrom Investing Activities
- -26.29
- Cashfrom Financing Activities
- -27.42
- Net Changein Cash
- 2.37
- Period
- 2019
- Total Revenue
- 546.52
- Selling/ General/ Admin Expenses Total
- 97.28
- Depreciation/ Amortization
- 20.07
- Other Operating Expenses Total
- 254.84
- Total Operating Expense
- 502.78
- Operating Income
- 43.74
- Net Income Before Taxes
- 36.74
- Net Income
- 20.49
- Diluted Normalized EPS
- 1.55
- Period
- 2019
- Period
- 2019
- Period
- 2024-03-31
- Total Revenue
- 225.24
- Selling/ General/ Admin Expenses Total
- 36.06
- Depreciation/ Amortization
- 11.04
- Other Operating Expenses Total
- 151.23
- Total Operating Expense
- 198.33
- Operating Income
- 26.91
- Net Income Before Taxes
- 20.24
- Net Income
- 14.18
- Diluted Normalized EPS
- 1.02
- Period
- 2024-03-31
- Total Assets
- 971.51
- Total Liabilities
- 523.16
- Total Equity
- 448.35
- Tangible Book Valueper Share Common Eq
- 29.2
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 108.85
- Cashfrom Investing Activities
- -86.99
- Cashfrom Financing Activities
- -30.12
- Net Changein Cash
- -8.26
- Period
- 2023-12-31
- Total Revenue
- 218.78
- Selling/ General/ Admin Expenses Total
- 34.69
- Depreciation/ Amortization
- 10.16
- Other Operating Expenses Total
- 151.45
- Total Operating Expense
- 196.3
- Operating Income
- 22.48
- Net Income Before Taxes
- 16.31
- Net Income
- 11.55
- Diluted Normalized EPS
- 0.83
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 225.01
- Selling/ General/ Admin Expenses Total
- 34.14
- Depreciation/ Amortization
- 9.95
- Other Operating Expenses Total
- 156.66
- Total Operating Expense
- 200.75
- Operating Income
- 24.26
- Net Income Before Taxes
- 18.8
- Net Income
- 13.59
- Diluted Normalized EPS
- 0.98
- Period
- 2023-09-30
- Total Assets
- 961.09
- Total Liabilities
- 539.68
- Total Equity
- 421.41
- Tangible Book Valueper Share Common Eq
- 27.46
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 41.37
- Cashfrom Investing Activities
- -39.48
- Cashfrom Financing Activities
- -4.12
- Net Changein Cash
- -2.23
- Period
- 2023-06-30
- Total Revenue
- 209.54
- Selling/ General/ Admin Expenses Total
- 34.06
- Depreciation/ Amortization
- 9.17
- Other Operating Expenses Total
- 147.59
- Total Operating Expense
- 190.81
- Operating Income
- 18.73
- Net Income Before Taxes
- 13.11
- Net Income
- 9.82
- Diluted Normalized EPS
- 0.71
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 195.28
- Selling/ General/ Admin Expenses Total
- 31.42
- Depreciation/ Amortization
- 8.73
- Other Operating Expenses Total
- 138.2
- Total Operating Expense
- 178.36
- Operating Income
- 16.92
- Net Income Before Taxes
- 14.04
- Net Income
- 10.6
- Diluted Normalized EPS
- 0.78
- Period
- 2023-03-31
- Total Assets
- 904.95
- Total Liabilities
- 501.8
- Total Equity
- 403.15
- Tangible Book Valueper Share Common Eq
- 26.4
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 127.16
- Cashfrom Investing Activities
- -158.21
- Cashfrom Financing Activities
- 38.22
- Net Changein Cash
- 7.17
- Period
- 2022-12-31
- Total Revenue
- 187.45
- Selling/ General/ Admin Expenses Total
- 30.92
- Depreciation/ Amortization
- 8.36
- Other Operating Expenses Total
- 130.94
- Total Operating Expense
- 170.22
- Operating Income
- 17.23
- Net Income Before Taxes
- 13.28
- Net Income
- 10.45
- Diluted Normalized EPS
- 0.75
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Artemis Medicare Services Technical
Moving Average
SMA
- 5 Day180.17
- 10 Day179
- 20 Day179.01
- 50 Day180.56
- 100 Day176.96
- 300 Day171.19
Artemis Medicare Services Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Thyrocare Technologies
- 643.25
- -1.55
- -0.24
- 722
- 511
- 3404.72
- Shalby
- 311
- 33.25
- 11.97
- 333.85
- 170
- 3333.68
- Artemis Medicare Services
- 183.35
- -0.4
- -0.22
- 199
- 117.25
- 2510.35
- Indraprastha Medical Corp
- 253.5
- 15.85
- 6.67
- 282.45
- 89.22
- 2323.91
- Krsnaa Diagnostics
- 675
- -12.55
- -1.83
- 788.6
- 448.7
- 2179.58
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Thyrocare Technologies
- 47.82
- 6.44
- 21.96
- 19.56
- Shalby
- 35.58
- 2.96
- 6.37
- 8.2
- Artemis Medicare Services
- 50.53
- 5.45
- -
- 4.59
- Indraprastha Medical Corp
- 17.75
- 4.61
- 19.59
- 6.73
- Krsnaa Diagnostics
- 39.15
- 2.7
- 14.3
- 11.74
Artemis Medicare Services Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 10-May-24
- Audited Results & Final Dividend
- 05-Apr-24
- Others
- 05-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 08-Aug-23
- Quarterly Results
- 05-May-23
- Audited Results & Dividend
- 01-Feb-23
- Quarterly Results
- 09-Nov-22
- Quarterly Results
- 11-Aug-22
- Quarterly Results
- 11-May-22
- Audited & Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 01-Aug-23
- 05-May-23
- AGM
- 20-Mar-23
- 16-Feb-23
- POM
- 13-Jul-22
- 04-Jun-22
- AGM
- 11-Sept-21
- 10-Aug-21
- POM
- 20-Jul-21
- 07-Jun-21
- AGM
- 16-Mar-21
- 12-Feb-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 10-May-24
- 05-Jul-24
- 05-Jul-24
- 0.45
- 05-May-23
- 14-Jul-23
- 14-Jul-23
- 0.45
- Ex-Splits
- Old FV
- New FV
- Description
- 23-Sept-21
- 10
- 1
- Stock split from Rs. 10/- to Re. 1/-.